Astrazeneca (Comparative Multiple Analysis)
Improve your investment analysis with by seeing the Astrazeneca's Discounted Cash Flow analysis, Astrazeneca's Warren Buffet analysis, and Astrazeneca's Weighted Average Cost of Capital (WACC) Analysis.
Notes on the Comparative Multiple Analysis of Astrazeneca
WikiWealth compares Astrazeneca's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Astrazeneca's comparative analysis.
Notes from the analysis:
1. WikiWealth uses quantitative measures to determine the multiple range for Astrazeneca.
Helpful Information for Astrazeneca's Analysis
How does this work? The Comparative Investment Analysis determines the value of Astrazeneca by comparing Astrazeneca financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.
Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Astrazeneca.
Also, see the Astrazeneca's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Astrazeneca's valuation conclusion for a quick summary.